Core Insights - The article highlights the importance of patents in measuring the innovation capability of companies in the pharmaceutical sector, specifically focusing on Funo Pharmaceutical's eight invention patents that cover critical areas such as drug preparation methods and new drug components [2][4]. Group 1: Patent and Innovation - Funo Pharmaceutical has developed eight invention patents, including methods for preparing Sulfate Polymyxin B and fermentation processes for Sulfate Neomycin, leading to the creation of the Chinese version of the Triple Antibiotic Ointment [2][4]. - The patented formulation has demonstrated a 34% increase in wound healing speed, showcasing the company's technological advantages in core ingredient purification and production [2][4]. Group 2: Market Position and Sales - Funo Pharmaceutical's compound Polymyxin B ointment has maintained the top sales position in China's hospital and outpatient antibiotic market for nine consecutive years, with annual sales exceeding 440 million yuan, which translates to an average of one unit sold every two seconds [4][5]. - The company has established three major R&D platforms in collaboration with top institutions, enhancing its competitive edge in the skin topical medication market [4]. Group 3: Brand Strategy and Consumer Engagement - Funo Pharmaceutical employs a dual-track strategy to enhance product strength and brand development, focusing on the efficacy of its core product, Funo Ointment, which combines three antibiotics for rapid bacterial elimination and wound healing [5][7]. - The company actively engages in brand communication to address public misconceptions about wound treatment, launching initiatives like the "Wound Healing Week" to raise awareness and promote its product's benefits [7][9]. Group 4: Recognition and Achievements - Funo Pharmaceutical has received numerous certifications and honors, including recognition as a top growth technology company and various provincial accolades, reflecting its technological depth and industry acknowledgment [7][9].